238 related articles for article (PubMed ID: 30008843)
1. Primary extra-nodal diffuse large B-cell lymphoma: A prognostic analysis of 141 patients.
Shen H; Wei Z; Zhou D; Zhang Y; Han X; Wang W; Zhang L; Yang C; Feng J
Oncol Lett; 2018 Aug; 16(2):1602-1614. PubMed ID: 30008843
[TBL] [Abstract][Full Text] [Related]
2. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
3. Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma.
Ma'koseh M; Tamimi F; Abufara A; Abusalem L; Salama O; Saleh Y; Khader R; Faiyoumi BA; Al-Rwashdeh M; Halahleh K
Cureus; 2021 Aug; 13(8):e16802. PubMed ID: 34513408
[TBL] [Abstract][Full Text] [Related]
4. Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity.
Eyre TA; Kirkwood AA; Wolf J; Hildyard C; Mercer C; Plaschkes H; Griffith J; Fields P; Gunawan A; Oliver R; Booth S; Martinez-Calle N; McMillan A; Bishton M; Fox CP; Collins GP; Hatton CSR
Br J Haematol; 2019 Oct; 187(2):185-194. PubMed ID: 31222719
[TBL] [Abstract][Full Text] [Related]
5. Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy.
Yhim HY; Kim JS; Kang HJ; Kim SJ; Kim WS; Choi CW; Eom HS; Kim JA; Lee JH; Won JH; Shim H; Huh J; Lee DH; Suh C; Kwak JY
Int J Cancer; 2012 Jul; 131(1):235-43. PubMed ID: 21823120
[TBL] [Abstract][Full Text] [Related]
6. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
7. Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma.
Kansara R
Curr Treat Options Oncol; 2018 Sep; 19(11):52. PubMed ID: 30203318
[TBL] [Abstract][Full Text] [Related]
8. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA; Olszewski AJ
Curr Treat Options Oncol; 2018 Jun; 19(8):38. PubMed ID: 29931605
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large B-Cell Lymphoma.
Chen GL; Li D; Cao S; Jiang S; Zhang Q; Jin J; Xia Z; Liu Y; Liu X; Zhu Y; Chen Y; Gu L; Hong X; Cao J; Tao R; Lv F
Mediterr J Hematol Infect Dis; 2022; 14(1):e2022066. PubMed ID: 36119461
[TBL] [Abstract][Full Text] [Related]
10. CNS relapse of diffuse large B cell Lymphoma A single centre experience.
Nazir A; Fawad ; Siddique N; Hameed A
Pak J Med Sci; 2017; 33(6):1454-1458. PubMed ID: 29492077
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological features and prognostic analysis of 151 patients with primary extra-nodal non-Hodgkin's lymphoma].
Wang C; Yuan C; He H; Bai O
Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):858-62. PubMed ID: 25620485
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.
Tai WM; Chung J; Tang PL; Koo YX; Hou X; Tay KW; Quek R; Tao M; Lim ST
Ann Hematol; 2011 Jul; 90(7):809-18. PubMed ID: 21229246
[TBL] [Abstract][Full Text] [Related]
13. [CNS involvement and the feasibility of intratecal chemotherapy administration in patients with a nodal form of diffuse large B-cell lymphoma not otherwise specified. Data of prospective study].
Magomedova AU; Misyurina AE; Mangasarova JK; Gorenkova LG; Margolin OV; Fastova EA; Kravchenko SK
Ter Arkh; 2019 Jul; 91(7):35-40. PubMed ID: 32598734
[TBL] [Abstract][Full Text] [Related]
14. Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.
Kridel R; Telio D; Villa D; Sehn LH; Gerrie AS; Shenkier T; Klasa R; Slack GW; Tan K; Gascoyne RD; Connors JM; Savage KJ
Br J Haematol; 2017 Jan; 176(2):210-221. PubMed ID: 27739058
[TBL] [Abstract][Full Text] [Related]
15. Diffuse large B-cell lymphoma.
Martelli M; Ferreri AJ; Agostinelli C; Di Rocco A; Pfreundschuh M; Pileri SA
Crit Rev Oncol Hematol; 2013 Aug; 87(2):146-71. PubMed ID: 23375551
[TBL] [Abstract][Full Text] [Related]
16. Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study.
Ma J; Li Q; Shao J; Ma Y; Lin Z; Kang H; Chen B
Cancer Manag Res; 2019; 11():10175-10185. PubMed ID: 31819650
[TBL] [Abstract][Full Text] [Related]
17. Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma.
Mannisto S; Vähämurto P; Pollari M; Clausen MR; Jyrkkiö S; Kellokumpu-Lehtinen PL; Kovanen P; Karjalainen-Lindsberg ML; d'Amore F; Leppä S
Eur J Cancer; 2019 Jul; 115():27-36. PubMed ID: 31082690
[TBL] [Abstract][Full Text] [Related]
18. CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.
Schmitz N; Zeynalova S; Nickelsen M; Kansara R; Villa D; Sehn LH; Glass B; Scott DW; Gascoyne RD; Connors JM; Ziepert M; Pfreundschuh M; Loeffler M; Savage KJ
J Clin Oncol; 2016 Sep; 34(26):3150-6. PubMed ID: 27382100
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological spectrum of Diffuse Large B Cell lymphoma: a study targeting population yet unexplored in Pakistan.
Mahmood H; Habib M; Aslam W; Khursheed S; Fatima S; Aziz S; Habib M; Faheem M
BMC Res Notes; 2021 Sep; 14(1):354. PubMed ID: 34507605
[TBL] [Abstract][Full Text] [Related]
20. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
Wang C; Li W; Liu C; He H; Bai O
Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
